Clinical Trial Update: RADA16 for Aquablation Day Case [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the RADA16 self-assembling peptide hydrogel in conjunction with Aquablation for a day-case procedure; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Hematuria
• Lower Urinary Tract Symptoms

Drugs mentioned

• RADA16 (self-assembling peptide hydrogel)

Snippet

Sponsor: NYU Langone Health | Conditions: Hematuria, Benign Prostatic Hyperplasia | Phase 2 | Status: NOT_YET_RECRUITING